Abbott Receives FDA Emergency Use Authorization for its COVID-19 IGM Antibody Blood Test

Originally published on Abbott.com

– Data demonstrates highly reliable test results with 99.56% specificity and 95.00% sensitivity for patients tested 15 days after symptom onset

– Availability of the new IgM blood test on the ARCHITECT® and Alinity™ platforms is part of Abbott’s effort to offer tests across the disease progression of COVID-19

– Abbott’s IgM test will give a more complete picture of where patients are in their recovery

Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for the company’s AdviseDx SARS-CoV-2 IgM (Immunoglobulin M) lab-based serology test for use on the ARCHITECT® and Alinity™ platforms. IgM antibody testing can play an important role in understanding if someone has developed antibodies in response to the virus, indicating a recent or prior infection.

The new IgM antibody test is Abbott’s latest test to support in the fight against COVID-19. Since the start of the pandemic, Abbott has received emergency use authorization for seven tests, including molecular tests, a rapid antigen test and an IgG antibody test.

“Abbott has developed tests to detect the virus at each stage of infection so doctors and their patients are equipped with knowledge of how they are responding to the virus and progressing through recovery,” said Robert B. Ford, president and chief executive officer, Abbott. “Antibody tests will continue to play an important role to better understand the virus, the prevalence of COVID-19 in an area and where a patient may be in their recovery.”

Understanding a person’s immune response with antibody tests

While molecular tests detect whether someone has the virus, antibody tests determine if someone had a previous infection by detecting antibodies, such as IgM and IgG.

Abbott first developed an IgG blood test, which often is the antibody that is longer-lasting in the body after infection. This test has been widely adopted and continues to play a key role in understanding if someone has recovered from the virus, as well as contact tracing and epidemiological studies.1

The IgM antibody, in comparison, is most useful for determining a recent infection as these antibodies become undetectable weeks to months following infection.2 Having this more complete picture of where a patient is in their recovery can help healthcare providers determine if treatment, isolation or follow-up visits are needed.

Similar to Abbott’s IgG blood test, the IgM test has demonstrated high reliability in both Abbott’s research and external virology laboratory studies. Abbott’s data demonstrated 99.56% specificity and 95.00% sensitivity for patients tested 15 days after symptom onset.

The IgM test is now available on Abbott’s ARCHITECT and Alinity platforms.

Latest News

George Floyd Justice in Policing Act

US House of Representatives Again Passes George Floyd Justice in Policing Act; Bill Now Moves to Senate for Vote

On Wednesday, March 3, the U.S. House of Representatives approved the George Floyd Justice in Policing Act by a vote of 220-212. The vote comes nine months after Floyd, a 46-year-old Black man, was killed by Minneapolis police officers last spring. Clare Foran of CNN reported that “House Democrats originally…

New Jersey

New Jersey Becomes One of First States in the US to Require Diversity Education in Schools

Following a bill signed by Governor Phil Murphy, New Jersey schools are now required to incorporate diversity and inclusion lessons within academic lesson plans. The Associated Press has reported that the new bill “aims to promote and highlight diversity, including economic, gender, sexual orientation and race.” “The state’s education commissioner…

Marriott International

Marriott International to Provide Associates Financial Award for COVID-19 Vaccination

Originally published on news.marriott.com. Marriott International is No. 1 on the 2020 DiversityInc Top 50 Companies for Diversity list. Vaccination Care Program to provide financial award, schedule flexibility and education Marriott International, Inc. (NASDAQ: MAR) today announced it has created the Vaccination Care Program, which will provide a financial award…

BASF Sponsors Chattanooga Engineers Week

Originally published at basf.com. BASF ranked No. 14 on The DiversityInc Top 50 Companies for Diversity list in 2020.   As part of its ongoing commitment to promoting the importance of engineering, as well as math, science and technical skills, BASF was a premier sponsor of Chattanooga Engineers Week during…